DexCom
DXCM
DXCM
881 hedge funds and large institutions have $23.6B invested in DexCom in 2024 Q3 according to their latest regulatory filings, with 97 funds opening new positions, 329 increasing their positions, 351 reducing their positions, and 199 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
40% less funds holding in top 10
Funds holding in top 10: 15 → 9 (-6)
44% less capital invested
Capital invested by funds: $42.3B → $23.6B (-$18.6B)
51% less first-time investments, than exits
New positions opened: 97 | Existing positions closed: 199
Holders
881
Holding in Top 10
9
Calls
$404M
Puts
$423M
Top Buyers
| 1 | +$439M | |
| 2 | +$402M | |
| 3 | +$160M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$110M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$99.5M |
Top Sellers
| 1 | -$429M | |
| 2 | -$418M | |
| 3 | -$267M | |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$183M |
| 5 |
Tiger Global Management
New York
|
-$131M |